Drugs / TECHNETIUM SESTAMIBI
TECHNETIUM SESTAMIBI
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | TECHNETIUM TC 99M SESTAMIBI | — | 2008-09-22 | fda.gov ↗ |
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02744053 | Nov 2016 → Apr 2028 expected | triple-negative breast carcinoma | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00162045 | Jan 2005 → May 2007 | Kawasaki disease | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01379677 | Feb 2011 → Nov 2013 | coronary artery disorder | Advanced Accelerator Applications | Completed | No outcome recorded |
| Phase 3 | NCT00162032 | Aug 2005 → May 2010 | Kawasaki disease | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00162357 | Apr 2004 → Dec 2005 | coronary restenosis, type 2 diabetes mellitus | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 4 | NCT00162344 | Dec 2003 → Dec 2005 | diabetes mellitus | Lantheus Medical Imaging | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00162331 Background | Jan 2005 → Jul 2007 | myocardial infarction | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01925170 Background | Apr 2009 → Jun 2013 | breast cancer | Mayo Clinic | Completed | No outcome recorded |
| — | NCT00620373 Background | Aug 2005 → Jun 2010 | breast cancer | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TECHNETIUM SESTAMIBI | ChEMBL registry synonym — accepted as the source's own label CHEMBL6069485 ↗ |
| Known as | CARDIOLITE | “CARDIOLITE® (Technetium Tc99m Sestamibi)” NCT00162045 ↗ |
| Known as | Miraluma | ChEMBL registry synonym — accepted as the source's own label CHEMBL6069485 ↗ |
| Known as | Sestamibi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01379677 ↗ |
| Known as | TC99M RP-30A | ChEMBL registry synonym — accepted as the source's own label CHEMBL6069485 ↗ |
| Known as | Technetium (99mTc) sestamibi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01925170 ↗ |
| Known as | Technetium tc-99m sestamibi kit | ChEMBL registry synonym — accepted as the source's own label CHEMBL6069485 ↗ |
| Known as | Technetium Tc99m Sestamibi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00162344 ↗ |
| Known as | Tecnecio (99mtc) sestamibi | ChEMBL registry synonym — accepted as the source's own label CHEMBL6069485 ↗ |
| Modality | Diagnostic / imaging agent | “myocardial perfusion imaging” NCT00162032 ↗ |
| Route | Intravenous | “Intravenous Use” NCT01379677 ↗ |